• Issue

    Annals of Neurology: Volume 65, Issue 4

    A07-A12, 361-485
    April 2009
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Message from the Editor

Economic Over-Stimulation?

S. Claiborne Johnston MD, PhD,  Stephen L. Hauser MD, 
  • Pages: A07-A08
  • First Published: 27 April 2009

NerveCenter

NerveCenter: Unabated increases in trial costs reflect evolving research milieu

  • Pages: A9-A11
  • First Published: 27 April 2009

Discoveries in Neuroscience

Discoveries in neuroscience

  • Page: A12
  • First Published: 27 April 2009

Invited Editorial

Cigarettes and amyotrophic lateral sclerosis: Only smoke or also fire?†

Marc G. Weisskopf PhD,  Alberto Ascherio MD, 
  • Pages: 361-362
  • First Published: 27 April 2009

Vascular endothelial growth factor gene transfer for diabetic polyneuropathy†

John A. Kessler MD, 
  • Pages: 362-364
  • First Published: 27 April 2009

Is prediction of outcome with magnetic resonance imaging in postresuscitation coma achievable and accurate?†

Eelco F. M. Wijdicks MD, PhD,  Harry J. Cloft MD, 
  • Pages: 364-366
  • First Published: 27 April 2009

Neurological Progress

Opportunistic infections and other risks with newer multiple sclerosis therapies†

Joseph R. Berger MD,  Sidney Houff MD, PhD, 
  • Pages: 367-377
  • First Published: 27 April 2009

Original Articles

Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort†

Valentina Gallo MD, MSc,  H. Bas Bueno-De-Mesquita MD, MPH, PhD,  Roel Vermeulen PhD,  Peter M. Andersen MD, DMSc,  Andreas Kyrozis MD, PhD,  Jakob Linseisen PhD,  Rudolph Kaaks PhD,  Naomi E. Allen DPhil,  Andrew W. Roddam DPhil,  Hendriek C. Boshuizen PhD,  Petra H. Peeters MD, PhD,  Domenico Palli MD,  Amalia Mattiello MD,  Sabina Sieri PhD,  Rosario Tumino MD,  Juan-Manuel Jiménez-Martín BSc,  María José Tormo Díaz MD,  Laudina Rodriguez Suarez MD, MPH,  Antonia Trichopoulou MD,  Antonio Agudo MD, MSc, PhD,  Larraitz Arriola MD, MSc,  Aurelio Barricante-Gurrea MD,  Sheila Bingham PhD,  Kay-Tee Khaw MBBChir,  Jonas Manjer MD, PhD,  Björn Lindkvist MD, PhD,  Kim Overvad PhD,  Flemming W. Bach MD,  Anne Tjønneland MD, PhD,  Anja Olsen MSc, PhD,  Manuela M. Bergmann PhD,  Heiner Boeing PhD,  Francoise Clavel-Chapelon PhD,  Eiliv Lund MD, PhD,  Göran Hallmans MD, PhD,  Lefkos Middleton MD, FRCP,  Paolo Vineis MD, MPH, FFPH,  Elio Riboli MD, MSc, MPH, 
  • Pages: 378-385
  • First Published: 27 April 2009

Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: A randomized, double-blinded trial†

Allan H. Ropper MD,  Kenneth C. Gorson MD,  Clifton L. Gooch MD,  David H. Weinberg MD,  Ann Pieczek RN,  James H. Ware PhD,  Joshua Kershen MD,  Adam Rogers MD,  Drasko Simovic MD,  Peter Schratzberger MD,  Rudolf Kirchmair MD,  Douglas Losordo MD, 
  • Pages: 386-393
  • First Published: 27 April 2009

Prognostic value of brain diffusion-weighted imaging after cardiac arrest†

Christine A. C. Wijman MD, PhD,  Michael Mlynash MD, MS,  Anna Finley Caulfield MD,  Amie W. Hsia MD,  Irina Eyngorn MD,  Roland Bammer PhD,  Nancy Fischbein MD,  Gregory W. Albers MD,  Michael Moseley PhD, 
  • Pages: 394-402
  • First Published: 27 April 2009
Free Access

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects†

Leslie M. Shaw PhD,  Hugo Vanderstichele PhD,  Malgorzata Knapik-Czajka PhD,  Christopher M. Clark MD,  Paul S. Aisen MD,  Ronald C. Petersen MD,  Kaj Blennow MD, PhD,  Holly Soares PhD,  Adam Simon PhD,  Piotr Lewczuk MD, PhD,  Robert Dean MD,  Eric Siemers MD,  William Potter MD,  Virginia M.-Y. Lee PhD,  John Q. Trojanowski MD, PhD,  Alzheimer's Disease Neuroimaging Initiative , 
  • Pages: 403-413
  • First Published: 27 April 2009

Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment†

Judy Pa PhD,  Adam Boxer MD, PhD,  Linda L. Chao PhD,  Adam Gazzaley MD, PhD,  Katie Freeman BS,  Joel Kramer PsyD,  Bruce L. Miller MD,  Michael W. Weiner MD,  John Neuhaus PhD,  Julene K. Johnson PhD, 
  • Pages: 414-423
  • First Published: 27 April 2009

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location†

Meizan Lai MD,  Ethan G. Hughes BS,  Xiaoyu Peng BS,  Lei Zhou BS,  Amy J. Gleichman BS,  Huidy Shu MD, PhD,  Sabrina Matà MD,  Daniel Kremens MD, JD,  Roberta Vitaliani MD,  Michael D. Geschwind MD,  Luis Bataller MD,  Robert G. Kalb MD,  Rebecca Davis BA,  Francesc Graus MD,  David R. Lynch MD, PhD,  Rita Balice-Gordon PhD,  Josep Dalmau MD, PhD, 
  • Pages: 424-434
  • First Published: 27 April 2009

Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models†

Carl E. Stafstrom MD, PhD,  Jeffrey C. Ockuly BS,  Lauren Murphree PhD,  Matthew T. Valley MS,  Avtar Roopra PhD,  Thomas P. Sutula MD, PhD, 
  • Pages: 435-447
  • First Published: 27 April 2009

Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein†

Scott Mintzer MD,  Christopher T. Skidmore MD,  Caitlin J. Abidin BS,  Megan C. Morales BS,  Inna Chervoneva PhD,  David M. Capuzzi MD, PhD,  Michael R. Sperling MD, 
  • Pages: 448-456
  • First Published: 27 April 2009

Localizing central nervous system immune surveillance: Meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis

Pia Kivisäkk MD, PhD,  Jaime Imitola MD,  Stine Rasmussen Ms Pharm,  Wassim Elyaman PhD,  Bing Zhu PhD,  Richard M. Ransohoff MD,  Samia J. Khoury MD, 
  • Pages: 457-469
  • First Published: 27 April 2009

Brief Communication

TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration†

Lina Benajiba MS,  Isabelle Le Ber MD,  Agnès Camuzat BS,  Mathieu Lacoste MD,  Catherine Thomas-Anterion MD,  Philippe Couratier MD,  Solenn Legallic BS,  François Salachas MD,  Didier Hannequin MD,  Marielle Decousus MD,  Lucette Lacomblez MD,  Eric Guedj MD,  Véronique Golfier MD,  William Camu MD,  Bruno Dubois MD, PhD,  Dominique Campion MD, PhD,  Vincent Meininger MD, PhD,  Alexis Brice MD,  French Clinical and Genetic Research Network on Frontotemporal Lobar Degeneration/Frontotemporal Lobar Degeneration with Motoneuron Disease , 
  • Pages: 470-473
  • First Published: 27 April 2009

Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis†

Mark P. Burgoon PhD,  Randall J. Cohrs PhD,  Jeffrey L. Bennett MD, PhD,  Sarah W. Anderson BS,  Alanna M. Ritchie BS,  Sabine Cepok PhD,  Bernhard Hemmer MD,  Don Gilden MD,  Gregory P. Owens PhD, 
  • Pages: 474-479
  • First Published: 27 April 2009

Letters/Replies

Predicting the unpredictable†

John Kamholz MD, PhD, 
  • Page: 480
  • First Published: 27 April 2009

Initiating therapy in Parkinson's disease†

William Weiner MD,  Eric Ahlskog MD,  Stewart Factor DO,  Oksana Suchowersky MD,  Stephen Reich MD, 
  • Pages: 480-481
  • First Published: 27 April 2009

Reply

Anthony H. Schapira MD, DSc, FRCP, FMedSci,  C. Warren Olanow MD, FRCPC, 
  • Page: 481
  • First Published: 27 April 2009

Creatine metabolism in combined methylmalonic aciduria and homocystinuria disease revisited†

Daria Younessi B.S.,  Kathryn Moseley MS, RD,  Shoji Yano MD, PhD, 
  • Pages: 481-482
  • First Published: 27 April 2009

Reply†

Olaf A. Bodamer MD, FACMG,  Fernando Scaglia MD, FACMG, 
  • Pages: 482-483
  • First Published: 27 April 2009

To test or not to test children with developmental disorders†

Isabelle Rapin MD, 
  • Page: 483
  • First Published: 27 April 2009

Metabolic evaluation in neurodevelopmental disabilities†

Michael Shevell MD, CM, FRCP(c), 
  • Pages: 483-484
  • First Published: 27 April 2009

Reply†

Hannelie M. Engbers MD,  Ruud Berger PhD,  Peter van Hasselt MD,  Tom de Koning MD, PhD,  Monique G. M. de Sain-van der Velden PhD,  Hester Kroes MD, PhD,  Gepke Visser MD, PhD, 
  • Page: 484
  • First Published: 27 April 2009

Correction

Free Access

Correction

  • Page: 485
  • First Published: 27 April 2009